FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017841963> ?p ?o ?g. }

• W2017841963 endingPage "2241" @default.
• W2017841963 startingPage "2229" @default.
• W2017841963 abstract "Germline mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 have been linked to the development of breast cancer, ovarian cancer, and other malignancies. Recent studies suggest that the BRCA1 and BRCA2 gene products may function in the sensing and/or repair of DNA damage. To investigate this possibility, we determined the effects of various DNA-damaging agents and other cytotoxic agents on the mRNA levels of BRCA1 and BRCA2 in the MCF-7 and other human breast cancer cell lines. We found that several agents, including adriamycin (a DNA intercalator and inhibitor of topoisomerase II), camptothecin (a topoisomerase I inhibitor), and ultraviolet radiation induced significant decreases in BRCA1 and BRCA2 mRNA levels. Decreased levels of BRCA1 and BRCA2 mRNAs were observed within 6–12 h after treatment with adriamycin and persisted for at least 72 h. Adriamycin also induced decreases in BRCA1 protein levels; but these decreases required several days. U.V. radiation induced dose-dependent down-regulation of BRCA1 and BRCA2 mRNAs, with significant decreases in both mRNAs at doses as low as 2.5 J/m2, a dose that yielded very little cytotoxicity. Adriamycin-induced down-regulation of BRCA1 and BRCA2 mRNAs was first observed at doses that yielded relatively little cytotoxicity and little or no apoptotic DNA fragmentation. Adriamycin and U.V. radiation induced distinct dose- and time-dependent alterations in the cell cycle distribution; but these alterations did not correlate well with corresponding changes in BRCA1 and BRCA2 mRNA levels. However, the adriamycin-induced reduction in BRCA1 and BRCA2 mRNA levels was correlated with p53 functional status. MCF-7 cells transfected with a dominant negative mutant p53 (143 val→ala) required at least tenfold higher doses of adriamycin to down-regulate BRCA1 and BRCA2 mRNAs than did parental MCF-7 cells or control-transfected MCF-7 clones. These results suggest that BRCA1 and BRCA2 may play roles in the cellular response to DNA-damaging agents and that there may be a p53-sensitive component to the regulation of BRCA1 and BRCA2 mRNA expression." @default.
• W2017841963 created "2016-06-24" @default.
• W2017841963 creator A5009069891 @default.
• W2017841963 creator A5017579441 @default.
• W2017841963 creator A5038476401 @default.
• W2017841963 creator A5041459397 @default.
• W2017841963 creator A5052303233 @default.
• W2017841963 creator A5060645493 @default.
• W2017841963 creator A5066598654 @default.
• W2017841963 creator A5077824760 @default.
• W2017841963 creator A5085173643 @default.
• W2017841963 date "1998-04-30" @default.
• W2017841963 modified "2023-09-27" @default.
• W2017841963 title "Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents" @default.
• W2017841963 cites W2772971838 @default.
• W2017841963 doi "https://doi.org/10.1038/sj.onc.1201752" @default.
• W2017841963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9619832" @default.
• W2017841963 hasPublicationYear "1998" @default.
• W2017841963 type Work @default.
• W2017841963 sameAs 2017841963 @default.
• W2017841963 citedByCount "79" @default.
• W2017841963 countsByYear W20178419632012 @default.
• W2017841963 countsByYear W20178419632014 @default.
• W2017841963 countsByYear W20178419632015 @default.
• W2017841963 countsByYear W20178419632016 @default.
• W2017841963 countsByYear W20178419632018 @default.
• W2017841963 countsByYear W20178419632019 @default.
• W2017841963 countsByYear W20178419632020 @default.
• W2017841963 countsByYear W20178419632021 @default.
• W2017841963 countsByYear W20178419632022 @default.
• W2017841963 crossrefType "journal-article" @default.
• W2017841963 hasAuthorship W2017841963A5009069891 @default.
• W2017841963 hasAuthorship W2017841963A5017579441 @default.
• W2017841963 hasAuthorship W2017841963A5038476401 @default.
• W2017841963 hasAuthorship W2017841963A5041459397 @default.
• W2017841963 hasAuthorship W2017841963A5052303233 @default.
• W2017841963 hasAuthorship W2017841963A5060645493 @default.
• W2017841963 hasAuthorship W2017841963A5066598654 @default.
• W2017841963 hasAuthorship W2017841963A5077824760 @default.
• W2017841963 hasAuthorship W2017841963A5085173643 @default.
• W2017841963 hasBestOaLocation W20178419631 @default.
• W2017841963 hasConcept C104317684 @default.
• W2017841963 hasConcept C109316439 @default.
• W2017841963 hasConcept C121608353 @default.
• W2017841963 hasConcept C134935766 @default.
• W2017841963 hasConcept C13514818 @default.
• W2017841963 hasConcept C143425029 @default.
• W2017841963 hasConcept C147897179 @default.
• W2017841963 hasConcept C153911025 @default.
• W2017841963 hasConcept C202751555 @default.
• W2017841963 hasConcept C2776694085 @default.
• W2017841963 hasConcept C2778616834 @default.
• W2017841963 hasConcept C2779682216 @default.
• W2017841963 hasConcept C2780427987 @default.
• W2017841963 hasConcept C2781303535 @default.
• W2017841963 hasConcept C2909462720 @default.
• W2017841963 hasConcept C29537977 @default.
• W2017841963 hasConcept C501734568 @default.
• W2017841963 hasConcept C502942594 @default.
• W2017841963 hasConcept C530470458 @default.
• W2017841963 hasConcept C54355233 @default.
• W2017841963 hasConcept C552990157 @default.
• W2017841963 hasConcept C55493867 @default.
• W2017841963 hasConcept C86803240 @default.
• W2017841963 hasConcept C96232424 @default.
• W2017841963 hasConceptScore W2017841963C104317684 @default.
• W2017841963 hasConceptScore W2017841963C109316439 @default.
• W2017841963 hasConceptScore W2017841963C121608353 @default.
• W2017841963 hasConceptScore W2017841963C134935766 @default.
• W2017841963 hasConceptScore W2017841963C13514818 @default.
• W2017841963 hasConceptScore W2017841963C143425029 @default.
• W2017841963 hasConceptScore W2017841963C147897179 @default.
• W2017841963 hasConceptScore W2017841963C153911025 @default.
• W2017841963 hasConceptScore W2017841963C202751555 @default.
• W2017841963 hasConceptScore W2017841963C2776694085 @default.
• W2017841963 hasConceptScore W2017841963C2778616834 @default.
• W2017841963 hasConceptScore W2017841963C2779682216 @default.
• W2017841963 hasConceptScore W2017841963C2780427987 @default.
• W2017841963 hasConceptScore W2017841963C2781303535 @default.
• W2017841963 hasConceptScore W2017841963C2909462720 @default.
• W2017841963 hasConceptScore W2017841963C29537977 @default.
• W2017841963 hasConceptScore W2017841963C501734568 @default.
• W2017841963 hasConceptScore W2017841963C502942594 @default.
• W2017841963 hasConceptScore W2017841963C530470458 @default.
• W2017841963 hasConceptScore W2017841963C54355233 @default.
• W2017841963 hasConceptScore W2017841963C552990157 @default.
• W2017841963 hasConceptScore W2017841963C55493867 @default.
• W2017841963 hasConceptScore W2017841963C86803240 @default.
• W2017841963 hasConceptScore W2017841963C96232424 @default.
• W2017841963 hasIssue "17" @default.
• W2017841963 hasLocation W20178419631 @default.
• W2017841963 hasLocation W20178419632 @default.
• W2017841963 hasOpenAccess W2017841963 @default.
• W2017841963 hasPrimaryLocation W20178419631 @default.
• W2017841963 hasRelatedWork W123654701 @default.
• W2017841963 hasRelatedWork W1620348927 @default.
• W2017841963 hasRelatedWork W1966168843 @default.
• W2017841963 hasRelatedWork W1974397158 @default.

• next